Phase I trial of ADR-002K for patients with ischemic cardiomyopathy who undergo coronary artery bypass surgery
Phase 1
- Conditions
- Ischemic Cardiomyopathy
- Registration Number
- JPRN-UMIN000038809
- Lead Sponsor
- Osaka University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have a combination of cardiovascular disease such as severe organic valvular disease or aortic aneurysm determined by investigator or co-investigator to affect clinical trial procedure 2) Patients whose participation in a clinical trial is considered inappropriate at the discretion of the investigator or co-investigator 3) Others
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Adverse event and safety evaluation related to this product 2) Efficacy(exploratory) 3) Feasibility
- Secondary Outcome Measures
Name Time Method 1) Cardiac function 2) Exercise tolerance 3) Other